The #iDR24 conference hosted a dynamic Poster Session, providing a vibrant platform to showcase cutting-edge…
tools@teamitresearch.com17 April 2024
REMEDi4ALL is hosting our 2nd Multi-stakeholder Meeting (MS) – Ensuring patient centricity in Osteogenesis Imperfecta…
tools@teamitresearch.com21 March 2024
ABOUT THIS EVENT This public workshop will be hosted by the FDA Office of Clinical…
tools@teamitresearch.com19 March 2024
REMEDi4ALL has launched a learning resources database where you can find a whole host of…
tools@teamitresearch.com10 January 2024
Pancreatic cancer, a rare and hard to treat type of cancer, is one of four…
tools@teamitresearch.com12 December 2023
The primary objective of the REMEDi4ALL Concierge is to actively engage with the repurposing community,…
Piret Baur28 September 2023
REMEDi4ALL is pleased to announce the first Multi-Stakeholder Meeting on drug repurposing in PANCREATIC CANCER.…
Ivette Corominas15 September 2023
Learn and discuss how REMEDi4ALL & the funders network can support your funding activities in…
Ivette Corominas9 June 2023
Please tell us a bit about yourself. I joined Beacon in October 2022 as Senior…
Ivette Corominas27 February 2023
Please tell us a bit about yourself. I joined EURORDIS in September 2022 as part…
Ivette Corominas22 February 2023
Please tell us a bit about yourself. I’m the CEO of Beacon, formerly an evolutionary…
Ivette Corominas15 February 2023
, Horizon Magazine published an article on drug repurposing featuring REMEDi4ALL project. According to the…
Ivette Corominas30 November 2022
Virginie Hivert, Director of Therapeutic Development at Eurordis, was recently interviewed by Phamaceutiques
Ivette Corominas30 November 2022
Every year, approximately 140.000 people are diagnosed with pancreatic cancer in Europe. This is one…
Ivette Corominas17 November 2022
Sign up to receive the latest project-related news and opportunities
You can unsubscribe at any time.
